I’m excited to share a deeper look into my professional journey in oncology research, clinical development, and regulatory science. Over the past 30+ years, I’ve had the opportunity to work across global biopharma organizations, advisory boards, and academic institutions, all focused on advancing patient-centered innovation. Here is my biography.

I’m pleased to share a more complete picture of my journey across structural chemistry and biology, drug discovery, higher education leadership, and diversity, equity, and inclusion work. Over the past several decades I’ve been fortunate to help build research infrastructure, launch student-success and DEI initiatives, and serve organizations committed to social and educational justice. As I move into the next chapter of advisory and board service, I remain committed to advancing opportunities for students, scientists, and communities who have too often been overlooked. Here is my biography.

I’m excited to share a deeper look into my professional journey and the experiences that have shaped my approach to leadership, sales strategy, and organizational growth. Over nearly four decades in the pharmaceutical and biopharmaceutical industries, I’ve had the privilege of leading incredible teams, launching impactful therapies, and learning from exceptional colleagues and mentors. As I continue supporting organizations through consulting and advisory work, I remain committed to service, development, and creating meaningful impact. Here is my biography.

I’m honored to share my professional biography, which reflects a career devoted to the development and commercialization of vaccines, anti-infectives, and diagnostics that address global microbial threats. My journey has taken me from regulatory service at the FDA to executive leadership in biotech and government programs shaping the future of infectious disease therapeutics.

I’m excited to share my professional biography, which reflects over 30 years of experience in pharma, biopharma, and FDA-regulated industries. My career has been dedicated to bridging scientific innovation with strategic market growth, leading cross-functional global teams, and driving measurable results in highly regulated environments. As I continue to explore part-time board and advisory opportunities, I look forward to contributing my expertise to organizations seeking strategic guidance and global perspective.

Over the course of my career, I’ve been privileged to serve in roles that blend scientific discovery, corporate leadership, and global health impact. From developing the first anti-TNF inhibitor to founding multiple biotech companies and leading critical medical research in the U.S. Navy, my work has always centered on advancing therapies that change lives. I’m excited to share a detailed look at my professional journey, values, and vision for the future. Here is my biography.

I'm a global medical affairs leader with over two decades of experience spanning clinical research, regulatory strategy, and pharmaceutical innovation across Latin America and the United States. Throughout my career, I've had the privilege of guiding high-performing teams, launching impactful therapies, and aligning regional execution with global vision—most recently as Head of Medical Affairs for Emerging Therapy Areas at Novo Nordisk. Passionate about advancing patient outcomes and fostering collaborative leadership, I bring a strategic, people-centered approach to everything I do in the healthcare space.

I'm excited to share my executive biography, which reflects over two decades of work in vaccine innovation, strategic investment, and scientific leadership across global biopharmaceutical landscapes. This journey has been rooted in a passion for transforming complex science into real-world solutions.

After a fulfilling career that has taken me around the world and across some of the most respected names in biotech and pharmaceuticals, I’m proud to share this executive biography that captures my professional journey, passions, and commitment to improving patient outcomes.

Omar Kassim is a globally respected executive in pharmaceutical development and supply chain strategy, known for his leadership in CDMO partnership management, external manufacturing, and complex contract negotiations. With over two decades of experience spanning finance, procurement, and technical operations, he has guided multinational teams through end-to-end product development, from pre-clinical research to commercial launch. Currently leading Takeda’s Pharmaceutical Sciences CDMO organization, Omar drives strategic network design, vendor governance, and asset integration across 175 global partners. His deep expertise in combination products and drug delivery systems, coupled with a strong foundation in finance and biochemistry, positions him as a key architect of cross-functional success in today’s evolving life sciences landscape.

After over 40 years of experience in pharmacy, biotech, and medical affairs, I’m excited to share my professional biography that reflects my journey from clinical care to corporate strategy, mentorship, and innovation. Whether supporting startups or collaborating with global medical societies, I’ve always been driven by the desire to connect science with purpose. Here is my biography.

Elizabeth M. Troll is a seasoned executive with over 42 years of global leadership in quality assurance, regulatory compliance, and governance within the pharmaceutical, biopharmaceutical, and healthcare industries. Renowned for her expertise in Quality Management Systems (QMS), vendor oversight, inspection readiness, and leadership development, Liz has played a pivotal role in shaping compliance frameworks that align regulatory standards with business efficiency. She has led quality and compliance initiatives at Endpoint Clinical, Novan Inc., QuintilesIMS, and Otsuka, driving strategic improvements and fostering a culture of operational excellence. A dynamic speaker and mentor, Liz is passionate about developing future leaders, advancing industry best practices, and supporting organizations in achieving regulatory success. With a strong commitment to integrity, respect, and continuous improvement, she seeks to leverage her expertise through board service and advisory roles, helping companies navigate complex regulatory landscapes and drive sustainable growth.

Excited to share my professional executive biography! With over 20 years of experience in biotech program management, drug development, and regulatory strategy, I have had the privilege of leading cross-functional teams, guiding early-stage startups, and ensuring successful clinical execution. If you're looking for strategic leadership, operational excellence, and industry expertise, I’d love to connect and explore opportunities to collaborate.

Barry M. Rosenfeld is a distinguished legal executive with extensive expertise in the biopharmaceutical and healthcare industries, known for his unwavering integrity, strategic foresight, and ability to navigate complex regulatory landscapes. With a career spanning transformative roles at Oyster Point Pharma, Novartis Group Companies, and his consultancy at B. Rosenfeld LLC, Barry has driven impactful legal strategies across corporate governance, intellectual property, product development, and M&A transactions. His deep knowledge and effective communication skills have enabled him to align legal frameworks with business objectives, guide cross-functional teams, and deliver solutions that balance risk and innovation, cementing his reputation as a trusted leader in high-stakes environments.

Celebrating the remarkable career of Helaine Gregory González, a powerhouse in healthcare and life sciences with over 30 years of strategic leadership. As President of Helaine Gregory LLC, Helaine has transformed her consulting firm into a trusted partner for biopharmaceutical and medical device clients, helping them achieve multimillion-dollar revenue growth through strategic market entry, PBM and payer contract negotiations, and operational excellence. With experience spanning roles at Fresenius Medical Care, KPMG, and UnitedHealth Group, she brings an unmatched depth of expertise to every engagement. A licensed attorney and former U.S. Army Reserve MAJ, Helaine is a bilingual force for positive change, leveraging her global perspective to navigate complex healthcare systems from San Juan, Puerto Rico.

I'm excited to share a bit about my professional journey as a bioprocess, quality assurance, and operations expert with over 30 years of experience in the biotechnology and pharmaceutical industries. From leading innovative bioprocess developments at companies like Inhibrx and Sutro Biopharma to pioneering sustainable marine microalgae cultivation systems at Verpond, I've had the privilege of working on projects that push the boundaries of science and technology. My expertise spans microbial and mammalian protein production, large-scale manufacturing, and regulatory compliance with agencies like the FDA, EMA, and SFDA. Through my consulting work at SBPD Consulting, I continue to focus on helping organizations streamline their operations, improve processes, and bring life-saving products to market efficiently. I'm passionate about translating biotech innovation into practical solutions that make a difference, and I look forward to connecting with others who share that vision.